Association of G-137C IL-18 promoter polymorphism with acute allograft rejection in renal transplant recipients

Transplantation

Volumn 86, Issue 11, 2008, Pages 1610-1614

  Kim, Chan Duck ^a   Ryu, Hye Myung ^a   Choi, Ji Young ^a   Choi, Hee Jeong ^a   Choi, Hyuk Joon ^a   Cho, Ji Hyung ^a   Park, Sun Hee ^a   Won, Dong Il ^a   Kim, Yong Lim ^a,b  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University Hospital   (South Korea)

Author keywords

Acute rejection; Interferon ; Interleukin 18; Kidney transplantation; Polymorphism

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 18;

ACUTE GRAFT REJECTION; ADULT; ANAMNESIS; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; RECIPIENT; ALLELE; BIOLOGICAL MODEL; BLOOD; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETICS; GRAFT REJECTION; METABOLISM; METHODOLOGY; MIDDLE AGED; RISK;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; GRAFT REJECTION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-18; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 58149355297     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31818870c4     Document Type: Article

References (20)

1. Kamoun M. Cellular and molecular parameters in human renal allo-graft rejection. Clin Biochem 2001; 34: 29.
2. Wilson AG, Symons JA, McDowell TL, et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195.
3. Marder B, Schröppel B, Murphy B. Genetic variability and transplantation. Curr Opin Urol 2003; 13: 81.
4. McInnes IB, Gracie JA, Leung BP, et al. Interleukin 18: A pleiotropic participant in chronic inflammation. Immunol Today 2000; 21: 312.
5. Stassen NA, Breit CM, Norfleet LA, et al. IL-18 promoter polymorphisms correlate with the development of post-injury sepsis. Surgery 2003; 134: 351.
6. Haas SL, Andreas Koch W, Schreiber S, et al. -137 (G/C) IL-18 promoter polymorphism in patients with inflammatory bowel disease. Scand J Gastroenterol 2005; 40: 1438.
7. Affleck DG, Bull DA, Albanil A, et al. Interleukin-18 production following murine cardiac transplantation: Correlation with histologic rejection and the induction of INF-gamma. J Interferon Cytokine Res 2001; 21: 1.
8. Striz I, Krasna E, Honsova E, et al. Interleukin 18 (IL-18) upregulation in acute rejection of kidney allograft. Immunol Lett 2005; 99: 30.
9. Giedraitis V, He B, Huang WX, et al. Cloning and mutation analysis of the human IL-18 promoter: A possible role of polymorphisms in expression regulation. J Neuroimmunol 2001; 112: 146.
10. Kolesar L, Novota P, Krasna E, et al. Polymorphism of interleukin-18 promoter influences the onset of kidney graft function after transplantation. Tissue Antigens 2007; 70: 363.
11. Simon T, Opelz G, Wiesel M, et al. Serial peripheral blood interleu-kin-18 and perforin gene expression measurements for prediction of acute kidney graft rejection. Transplantation 2004; 77: 1589.
12. Melnikov VY, Ecder T, Fantuzzi G, et al. Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest 2001; 107: 1145.
13. Daemen MA, van't Veer C, Wolfs TG, et al. Ischemia/reperfusion-induced IFN-gamma up-regulation: Involvement of IL-12 and IL-18. J Immunol 1999; 162: 5506.
14. Parikh CR, Jani A, Mishra J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006; 6: 1639.
15. Wyburn K, Wu H, Yin J, et al. Macrophage-derived interleukin-18 in experimental renal allograft rejection. Nephrol Dial Transplant 2005; 20: 699.
16. Yoshimoto T, Takeda K, Tanaka T, et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: Synergism with IL-18 for IFN-gamma production. J Immunol 1998; 161: 3400.
17. Micallef MJ, Ohtsuki T, Kohno K, et al. Interferon-gamma-inducing factor enhancesThelper1 cytokine production bystimulated human T cells: Synergism with interleukin-12 for interferon-gamma production. Eur J Immunol 1996; 26: 1647.
18. Wyburn K, Wu H, Chen G, et al. Interleukin-18 affects local cytokine expression but does not impact on the development of kidney allograft rejection. Am J Transplant 2006; 6: 2612.
19. Marshall SE, McLaren AJ, Mckinney EF,etal. Donor cytokine genotype influences the development of acute rejection after renal transplantation. Transplantation 2001; 71: 469.
20. Hoffmann S, Park J, Jacobson LM, et al. Donor genomics influence graft events: The effect of donor polymorphisms onacute rejection and chronic allograft nephropathy. Kidney Int 2004; 66: 1686.